#SVNS The entire boardroom has been engineered for deal execution. Anything under the recent placing price 0.33p is simply supplying stock to the smart money anticipating Singer Capital's 1.6p target price. Overhang being digested.

#HREE advancing on all fronts Chairman Ivan Murphy met Madagascar’s new Minister of Mines, Chief of Staff & partners to progress licensing for Ampasindava 🇲🇬 Next stop: Washington D.C. 🇺🇸 for continued discussions with US gov’t agencies on rare earth supply chain security.

📍Madagascar |🇲🇬 Chairman Ivan Murphy meets new Minister of Mines & Chief of Staff. #HREE advancing licence in close partnership with government. Next stop: 🇺🇸Washington D.C. for talks with US agencies on US mineral security. #Ampasindava #RareEarths #CriticalMinerals

#HREE is actively aligning with US strategic priorities 🇺🇸 Chairman Ivan Murphy: “We’ve been in DC, engaging with US agencies and corporates. The OTC listing is just step one.” One of the world’s largest ionic clay #RareEarth deposits outside China 🇨🇳

🇺🇸 At the US Embassy in Madagascar 🇲🇬 #HREE Chairman Ivan Murphy met with US officials as part of Harena’s ongoing engagement with government agencies. Supporting US goals for secure, non-Chinese #RareEarth supply.

#KDNC Lovely news Update on Offtake Financing for the Azteca Plant | Company Announcement | Investegate investegate.co.uk/announcement/r…

#ALL #Lithium 📈

With spodumene auctions above $1200 the only thing holding #ALL Atlantic Lithium back is their mining lease ratification (at committee stage right now). <10.5p to buy with a target of 20p - 30p on ratification which could happen as soon as next week. Ratification also unlocks

#REE 94 days since the company AltonaRareEarths said it anticipated "material progress over the coming weeks" on USTDA. Simple question for the AGM next Wednesday: Where are we with USTDA?

#VAL ValiRx is in discussions with several potential partners to progress Cytolytix, including a major pharmaceutical company and further non-dilutive funding options with our academic partners.

#VAL Don’t think this OFFER will be available next week 👍 Remember #IMM £5m to £70m move on nothing #HEMO £10m to £100m #NFX £1m to £10m With #VAL deals on the table followed by more £2m MCAP can turn into £20m within days and still be undervalued compared to peers

#VAL VAL 401 - Alone £16m + Royalties with £6m upfront payment Not including additional portfolio of drugs in licensing stage Mad valuation at just £2m That’s some crazy upside 💪 investment case One of the best on AIM

#SVNS SVN-015 accepted into US NIDA funded programme NIDA acceptance validates the asset & secures non-dilutive funding. The $3M/yr NIH grant path is the real money shot here. Targeting Meth/Cocaine—a virgin market with no drugs. investegate.co.uk/announcement/r…

#VAL 🔥 That’s interesting AstraZeneca 🤔 Panellists • Hannah Bolt, Head of Peptide Discovery, Director, AstraZeneca • Mark Eccleston, Chief Executive Officer, ValiRx • Alastair Hay, Vice President, Almac • Anders Dahlén, Director, AstraZeneca linkedin.com/posts/peptide-…

#VAL Join the dots Charles Chen AZ 🤔 Looks like AstraZeneca is the 'major pharmaceutical company' that VAL is in discussions with over progressing Cytolytix 🔷ValiRx in discussions with several potential partners to progress Cytolytix,including a major pharmaceutical company

#VAL That was a storming finish yesterday So much talk and interest picked up lately Could this be the turning point and show us the real value around £20m minimum where it should be Eyes on the updates 📈

#VAL Nice steady volume again today strengthening the share price Starting off slow again but be have been seeing the large block buyer later in the day 👀 Free float getting lower daily Won’t be surprised to see it break 0.50 in the next few trading days

At this rate we could end up passing the 0.4 mark today 👀 The 0.5 Warrants not looking a million miles away now 📈#VAL

#VAL That’s what you call buying 1 single buyer Knows something 🤔

#VAL Not long before it pops Limits in place Only 300k shares (£1k)